查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1840696

全球胃內球囊市場（按類型、最終用戶、分銷管道和應用）預測 2025-2032

Intragastric Balloon Market by Type, End User, Distribution Channel, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，胃內球囊市場將成長 4,175 萬美元，複合年成長率為 8.36%。

主要市場統計數據
基準年2024年 2195萬美元
預計2025年 2379萬美元
預測年份：2032年 4175萬美元
複合年成長率（%） 8.36%

策略性地介紹胃內球囊的演變，強調臨床整合、提高安全性和相關人員的採用優先事項

胃內球囊領域正從小眾的體重管理替代方案發展成為多學科肥胖治療途徑的主流輔助。器械材料、輸送技術和臨床通訊協定的進步提高了手術安全性，擴大了臨床可接受性，迫使醫院和專科診所重新評估治療流程。隨著相關人員尋求可擴展的解決方案來應對日益成長的肥胖和代謝併發症，胃內球囊在保守藥物治療和減肥手術之間佔據著獨特的地位，提供了一種可逆的微創治療方案，可以納入綜合護理計劃。

臨床結果和患者體驗仍然是推廣應用的關鍵。近期的手術最佳化和術後追蹤方案減少了不利事件，並且與行為和藥物支持相結合，提高了減重效果的持久性。付款人和醫療系統越來越關注患者的選擇標準、現實世界治療結果的持久性以及與其他治療方法相比的成本效益。因此，商業策略現在強調可靠的臨床證據、精簡的供應物流，以及與減重中心、門診專科診所和醫院系統的夥伴關係，將胃內球囊納入縱向減重治療路徑。

在這種環境下，製造商和醫療系統領導者必須在設備創新與培訓、報銷途徑和中心準備等實際考量之間取得平衡。不斷變化的法規、臨床醫生教育和患者需求的相互作用，將繼續影響不同醫療環境中的定位和應用。

技術進步、綜合護理途徑和醫療保健服務模式如何改變臨床應用和商業性差異化

在技​​術進步、多學科護理模式以及對個人化治療日益重視的推動下，胃內球囊領域正在發生重大變化。設備創新者改進了填充材、錨定機制和回收技術，並改進了患者選擇通訊協定，從而降低了併發症率並擴大了候選對象合格。同時，行為諮商、數位監測和輔助藥物治療的整合已將治療結果轉向更永續的體重管理，鼓勵臨床醫生將水球視為綜合治療策略的一部分，而非一項獨立的療法。

市場動態也在改變。醫療保健機構正在重新配置其服務線，以提供門診和專科診所的診療服務，從而最大限度地降低醫院資源利用率，並提高患者的便利性。同時，製造商正在透過捆綁式價值主張實現差異化，這些主張包括臨床醫生培訓、追蹤計畫和患者參與工具。儘管監管審查仍然嚴格，但更清晰的指導方針正在幫助那些正在調整報銷框架以認可肥胖干預措施的長期健康經濟效益的地區簡化相關措施的採用。

因此，競爭正轉向注重治療後療效、整合的護理路徑以及減少醫患摩擦的商業模式。這種轉變相關人員。

評估美國2025 年關稅如何改變整個胃內球囊生態系統的供應鏈策略、定價透明度和採購慣例

2025年美國關稅變化的累積影響正迫使設備製造商、經銷商和醫療保健機構採購團隊重新評估進口胃內球囊及相關耗材的供應鏈彈性和成本分攤。關稅調整提高了某些類別零件和成品的到岸成本，促使製造商將增加的成本轉嫁給下游企業，同時探索替代採購和本地生產以保護利潤率。醫院和診所的採購團隊正在透過重新談判合約、尋求更長期的供應協議以及優先選擇擁有多元化生產地點的供應商來應對這一挑戰。

除了單位成本之外，關稅也提升了庫存規劃和前置作業時間可視性的策略重要性。供應商正擴大與分銷商合作，以確保可預測的交貨，並最大程度地降低關稅導致的價格突然波動的風險。一些製造商正在加快對經銷商製造能力和第三方夥伴關係的投資，以降低關稅風險並提高對臨床需求的應對力。法規合規性、海關複雜性和文件要求也消耗了額外的管理資源，促使供應鏈團隊投資於海關專業知識和數位追蹤工具。

在這種環境下，強調訂單總成本、保固範圍和服務水準承諾透明度的商業策略正獲得越來越多的支援。積極調整合約實務、對沖供應路線並向買家明確傳達成本影響的相關人員，將更有能力在關稅帶來的不利因素下保持採用勢頭。

詳細的細分分析將設備類型、最終用戶設定、通路和臨床應用與商業化和臨床採用需求聯繫起來

了解細分動態對於塑造產品開發和商業性推廣至關重要。按類型，對內視鏡和非內視鏡應用市場進行研究，並進一步研究基於氣體和基於液體的應用以用於內視鏡應用。這種區別會影響設備設計、程序和安裝後管理，並指南哪些臨床團隊參與培訓和跟進。另外，按最終用戶，對減肥中心、診所和醫院的市場進行研究。在診所內，進一步研究了門診和專科診所。這些環境中的基礎設施、麻醉能力和護理途徑的差異決定了首選的設備配置和服務包。此外，基於分銷管道，對醫院和零售藥局的市場進行研究。分銷策略必須考慮專業分銷經銷商在支援庫存管理、臨床醫生採購流程、培訓和現場物流方面的作用。最後，根據應用，對術前最佳化和減重市場進行研究。這種臨床細分影響轉診模式、付款人互動和病患支援服務整合。

綜合起來，這些細分軸揭示了臨床需求的集中點以及商業化努力應在何處進行協調。例如，充氣式和液體式內視鏡選項對不同的病患小組和手術流程具有吸引力，診所和門診專科機構可能會優先考慮能夠最大程度縮短手術時間和減少恢復需求的設備。與醫院藥房的經銷夥伴在供應鏈透明度和臨床醫生互動方面與零售藥房模式有顯著差異。基於應用的細分凸顯了對術前最佳化和主要減重結果數據的需求，從而能夠向外科醫生、基層醫療醫生和多學科護理團隊通訊。

實際上，製造商需要使其設備功能、培訓計劃和商業條款與目標區域的主導詳細情形保持一致，確保產品變化和服務產品符合最終用戶和分銷合作夥伴的業務現實。

美洲、歐洲、中東和非洲以及亞太市場的區域採用促進因素、監管差異和分銷需求

區域動態顯著影響腹腔內球囊的臨床應用模式、監管發展和分銷策略。在美洲，隨著支付者和醫療服務提供者優先考慮非手術干預措施，越來越多的成熟減重中心和門診診所正在將胃內球囊納入其治療方案。該地區青睞那些在不同患者群體中表現出可重複結果且可整合到現有多學科肥胖症治療項目中的解決方案。同時，歐洲、中東和非洲市場差異龐大，法律規範、報銷環境和臨床實務模式也存在顯著差異。雖然集中式醫院系統和國家指南推動了某些市場的採用，但在其他市場，支付方覆蓋範圍和臨床醫生經驗的差異需要有針對性的教育舉措和區域證據的產生。在亞太地區，肥胖和代謝性疾病盛行率的上升、多樣化的醫療服務模式以及對微創替代方案的關注，正在推動該技術的快速應用。在多個亞太市場，大量的專科診所患者和消費者對微創治療方案的興趣，促使製造商開發本地化的培訓和患者援助計劃。

不同地區的供應鏈、監管時間表和報銷途徑的成熟度各不相同，這些因素決定了其市場策略。例如，擁有強大門診醫療網路的地區可能會優先考慮針對當日手術和有限麻醉資源而最佳化的設備。相反，以院內醫療為主的地區可能會從提供包括臨床醫生培訓、術後監測和長期追蹤在內的綜合服務中獲得更大的收益。有效的區域策略應將全球臨床證據與本地相關的真實世界數據和相關人員的參與相結合，以在臨床醫生、付款人和患者中建立持久的認可。

競爭對手的策略強調設備創新、臨床服務捆綁和夥伴關係模式，以推動採用和營運規模

胃內球囊領域的主要企業正圍繞著幾個策略要點展開整合：臨床差異化、服務導向的商業化以及營運擴充性。領先的設備開發商正在投資於設備設計的迭代改進，以減少不利事件並簡化放置和移除工作流程。各公司也在擴大其產品組合，涵蓋氣體和液體填充的內視鏡選項，以適應不同的臨床醫生偏好和患者生理狀況。越來越多的公司不僅將設備捆綁銷售，還將培訓、患者參與平台和後續服務捆綁銷售，以改善治療效果並減輕醫務人員的負擔。

戰略夥伴關係已成為加速應用的熱門途徑。與減肥中心、專科診所和分銷夥伴的合作，使公司能夠在建立轉診網路的同時，展示其在現實世界中的有效性。一些公司正在尋求區域製造合作關係，以提高供應彈性並最佳化土地成本結構。同時，需要證據生成（前瞻性註冊、多中心研究、衛生經濟分析）來實現競爭差異化，支持付款人參與並為臨床指南提供資訊。成功平衡產品創新、擴充性服務交付和可靠臨床證據的公司正在獲得大型醫療系統、門診病人提供者和專科診所的支持，這些機構尋求可預測的結果和精簡的營運。

領導者可以採取切實可行的商業、臨床和供應鏈措施，建立彈性採用路徑，並將相關人員置於價值交付的中心

為了促進胃內球囊解決方案的永續應用，產業領導者應優先考慮一種整合方法，將臨床證據、服務交付和供應鏈韌性結合起來。首先，投資於可靠的真實世界證據和患者報告結果，以證實術前最佳化和獨立減重應用中的臨床主張，促進付款方討論和臨床醫生的認可。其次，根據減重中心、門診診所和專科診所的需求，創建全面的培訓和認證路徑，減少手術差異並增強安全性。第三，多樣化採購和物流策略，以減輕關稅波動的影響並縮短前置作業時間。

此外，我們將調整商業模式，透過提供透明的醫療總成本溝通和靈活的合約條款，支持醫院和零售藥局管道的不同購買行為。我們將利用數位化病人參與工具和多學科支持項目，提高生活方式干涉的依從性，並增強追蹤能力，同時避免給臨床工作人員帶來過重負擔。最後，我們將與相關人員進行策略合作，建立基於價值的方案和覆蓋途徑，以反映綜合肥胖治療的長期臨床和經濟效益。這些措施將強化胃內球囊的價值提案，並實現永續、可擴展的推廣應用。

結合臨床訪談、監管審查和供應鏈分析的綜合混合方法研究，檢驗可行的見解

本報告所依據的研究採用了混合方法，以確保研究結果能反映臨床實際情況和商業性動態。主要輸入包括對減肥中心、門診專科診所和醫院計畫的臨床醫生進行結構化訪談，以及與活躍於醫院藥房和零售藥房管道的採購負責人和分銷合作夥伴進行討論。次要輸入包括監管出版刊物、臨床試驗註冊中心以及關注設備安全性、有效性和患者報告結果的同行評審文獻。透過對這些資料來源進行三角測量，我們能夠識別出關於設備性能、操作流程和應用障礙的一致主題。

分析方法包括將器械設計屬性（例如填充材和輸送系統）與手術結果和護理環境要求進行比較評估。供應鏈和商業影響分析著重於不同最終用戶環境下的採購行為，並包含情境測試，以評估對資費變化和採購中斷的回應。研究結果經臨床醫生顧問小組和供應鏈專家檢驗，以確保其具有實際意義，並為製造商、醫療保健提供者和付款相關人員提供切實可行的指導。調查方法和資料來源強調透明度，並優先考慮臨床適用性和對決策者的策略效用。

綜合結論強調了決定在不同醫療環境中成功採用的臨床、商業性和營運槓桿

摘要，胃內球囊已發展成為現代肥胖治療中具有戰略意義的重要工具，其定位介於保守的醫療治療和外科手術之間。設備創新、臨床通訊協定的改進以及整合的護理模式提高了安全性並擴大了應用範圍。然而，商業性的成功不僅僅取決於設備的性能；它需要可證明的療效、清晰的報銷途徑、彈性的供應鏈以及支持臨床醫生培訓和患者參與的可擴展服務模式。

不同的關稅和區域監管差異帶來了複雜性，但也為製造商提供了透過透明定價、本地夥伴關係和循證商業策略實現差異化的機會。透過讓產品開發與最終用戶需求保持一致——考慮到氣體和液體內視鏡選項的差異、不同的臨床基礎設施以及分銷管道要求——相關人員可以創建引人入勝的價值提案，引起醫療服務提供者和付款人的共鳴。未來的道路青睞那些將臨床嚴謹性與實用商業化相結合，以實現可重複結果和高效醫療服務的人。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 擴大採用可調節胃內球囊來實現個人化的體重管理通訊協定
  • 將胃內球囊治療與數位健康平台結合，實現遠端患者監護和參與
  • 開發可生物分解的胃內球囊系統，無需內視鏡取出手術
  • 一項評估胃內球囊與GLP-1促效劑合併使用協同減重效果的臨床研究
  • 形狀記憶聚合物球囊的出現，可根據胃動力的變化進行動態體積調節
  • 新型充氣胃內球囊獲監理機關核准，可最大程度減少病患不適及手術併發症
  • 增強型胃內球囊應用解決非酒精性脂肪肝和METABOLIC INC.症候群的管理
  • 內視鏡設備製造商與遠端醫療提供者之間的策略合作夥伴關係擴大了球囊治療的可及性

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

第8章胃內球囊市場（按類型）

  • 內視鏡檢查
    • 氣體
    • 液體
  • 非內視鏡

第9章胃內球囊市場（依最終用戶）

  • 肥胖治療中心
  • 診所
    • 門診
    • 專科診所
  • 醫院

第 10 章胃內球囊市場（依通路）

  • 醫院藥房
  • 零售藥局

第11章胃內球囊市場（依應用）

  • 術前最佳化
  • 減重

第12章胃內球囊市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章胃內球囊市場：依類別

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國胃內球囊市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Apollo Endosurgery, Inc.
    • Allurion Technologies, Inc.
    • Obalon Therapeutics, Inc.
    • ReShape Lifesciences, Inc.
    • Spatz Medical, Inc.
    • MedSil, UAB
    • Silimed, SA
    • ENDALIS GmbH
    • GI Dynamics, Inc.
    • BARIATRX Ltd.
Product Code: MRR-7C5681F8681E

The Intragastric Balloon Market is projected to grow by USD 41.75 million at a CAGR of 8.36% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 21.95 million
Estimated Year [2025] USD 23.79 million
Forecast Year [2032] USD 41.75 million
CAGR (%) 8.36%

Strategic introduction to intragastric balloon evolution highlighting clinical integration, safety improvements, and stakeholder priorities for adoption

The intragastric balloon segment has evolved from a niche alternative for weight management into a mainstream adjunct within multidisciplinary obesity care pathways. Advances in device materials, delivery techniques, and clinical protocols have increased procedural safety and broadened clinical acceptance, prompting hospitals and specialty clinics to re-evaluate treatment algorithms. As stakeholders seek scalable solutions to address rising rates of obesity and metabolic comorbidities, intragastric balloons occupy a distinct role between conservative medical therapy and bariatric surgery, offering a reversible, minimally invasive option that can be integrated into comprehensive care plans.

Clinical outcomes and patient experience remain central to adoption. Recent procedural optimizations and post-placement follow-up protocols have reduced adverse event profiles while improving sustained weight reduction when combined with behavioral and pharmacologic support. Payers and health systems are increasingly focused on patient selection criteria, real-world durability of outcomes, and cost-effectiveness relative to other interventions. Consequently, commercial strategies now emphasize robust clinical evidence, streamlined supply logistics, and partnerships with bariatric centers, outpatient specialty clinics, and hospital systems to embed intragastric balloons into longitudinal obesity care pathways.

Given this environment, manufacturers and health system leaders must balance device innovation with pragmatic considerations around training, reimbursement pathways, and center readiness. The interplay of regulatory evolution, clinician education, and patient demand will continue to shape positioning and uptake across diverse care settings.

How technological refinements, integrated care pathways, and provider delivery models are reshaping clinical adoption and commercial differentiation

The intragastric balloon landscape is undergoing transformative shifts driven by technological refinement, multidisciplinary care models, and heightened focus on personalized therapy. Device innovators have introduced modifications in fill media, anchoring mechanisms, and retrieval techniques, which, together with improved patient selection protocols, have reduced complication rates and expanded candidate eligibility. Concurrently, the integration of behavioral counseling, digital monitoring, and adjunctive pharmacotherapy has shifted outcomes toward more durable weight management, prompting clinicians to view balloons as one component of a comprehensive treatment strategy rather than a stand-alone cure.

Market-facing dynamics are also changing. Providers are reconfiguring service lines to offer outpatient and specialty clinic-based procedures, minimizing hospital resource utilization and enhancing patient convenience. At the same time, manufacturers are differentiating through bundled value propositions that include clinician training, follow-up programs, and patient engagement tools. Regulatory scrutiny remains rigorous, but clearer guidance has helped streamline adoption in regions where reimbursement frameworks are adapting to recognize long-term health economic benefits of obesity interventions.

As a result, competition is increasingly centered on post-procedural outcomes, care pathway integration, and commercial models that reduce friction for providers and patients. These shifts favor stakeholders who can demonstrate clinical efficacy within coordinated care programs and who can support scalable, low-complexity delivery models across a range of clinical settings.

Assessment of how 2025 United States tariffs have altered supply chain strategies, pricing transparency, and procurement practices across the intragastric balloon ecosystem

The cumulative impact of tariff changes in the United States during 2025 has prompted device manufacturers, distributors, and provider procurement teams to reassess supply chain resilience and cost allocation for imported intragastric balloons and related consumables. Tariff adjustments have led to higher landed costs for certain categories of components and finished devices, prompting manufacturers to pass some cost increases downstream while simultaneously exploring alternative sourcing and localized manufacturing to protect margins. Procurement teams within hospitals and clinics have responded by renegotiating contracts, seeking longer-term supply agreements, and prioritizing suppliers with diversified production footprints.

Beyond unit costs, tariffs have amplified the strategic importance of inventory planning and lead-time visibility. Providers have increased engagement with distributors to secure predictable deliveries and to minimize exposure to sudden tariff-driven price swings. Some manufacturers have accelerated investments in regional manufacturing capabilities and third-party partnerships to mitigate tariff risk and improve responsiveness to clinical demand. Regulatory compliance, customs clearance complexity, and documentation requirements have also consumed additional administrative resources, prompting supply chain teams to invest in customs expertise and digital tracking tools.

In this context, commercial strategies that emphasize transparency around total landed costs, warranty coverage, and service-level commitments have gained traction. Stakeholders that proactively adapt contracting practices, hedge supply routes, and communicate clear cost implications to purchasers will be better positioned to sustain adoption momentum despite tariff-induced headwinds.

In-depth segmentation analysis linking device type, end-user setting, distribution route, and clinical application to commercialization and clinical adoption imperatives

Understanding segmentation dynamics is essential to shaping product development and commercial outreach. Based on Type, market is studied across Endoscopic and Non Endoscopic, with Endoscopic further studied across Gas and Liquid; this distinction influences device design, procedural technique, and post-placement management, and it guides which clinical teams are engaged for training and follow-up. Separately, based on End User, market is studied across Bariatric Centers, Clinics, and Hospitals, with Clinics further studied across Outpatient Clinics and Specialty Clinics; differences in infrastructure, anesthesia capability, and care pathways across these settings determine preferred device profiles and service bundles. Furthermore, based on Distribution Channel, market is studied across Hospital Pharmacies and Retail Pharmacies, and distribution strategy must consider inventory management, clinician procurement processes, and the role of specialty distributors in supporting training and on-site logistics. Finally, based on Application, market is studied across Preoperative Optimization and Weight Loss, and this clinical segmentation affects referral patterns, payer interactions, and the alignment of patient support services.

Taken together, these segmentation axes reveal where clinical demand concentrates and where commercialization efforts should be tailored. For example, gas-filled versus liquid-filled endoscopic options appeal to different patient groups and procedural workflows, while clinics and outpatient specialty settings may prioritize devices that minimize procedure time and recovery needs. Distribution partnerships with hospital pharmacies will differ markedly from retail pharmacy models in terms of supply chain transparency and clinician interactions. Application-based segmentation underscores the need for outcome data specific to preoperative optimization versus primary weight reduction, which in turn shapes messaging to surgeons, primary care physicians, and multidisciplinary care teams.

In practical terms, manufacturers should align device features, training programs, and commercial terms with the dominant segmentation profiles in their target geographies, ensuring that product variants and service offerings match the operational realities of the end users and distribution partners they intend to serve.

Regional adoption drivers, regulatory variability, and distribution imperatives across the Americas, Europe Middle East & Africa, and Asia-Pacific markets

Regional dynamics significantly influence clinical adoption patterns, regulatory pathways, and distribution strategies for intragastric balloons. In the Americas, established bariatric centers and a growing number of outpatient clinics are integrating intragastric balloons into therapy mixes as payers and providers place greater emphasis on non-surgical interventions. This region favors solutions that demonstrate reproducible outcomes in diverse patient populations and that can integrate with existing multidisciplinary obesity programs. Meanwhile, Europe, Middle East & Africa present a heterogeneous landscape where regulatory frameworks, reimbursement environments, and clinical practice patterns vary widely; in some markets, centralized hospital systems and national guidelines accelerate adoption, whereas in others, variability in payer coverage and clinician experience necessitate targeted education initiatives and local evidence generation. Asia-Pacific exhibits rapid uptake driven by rising prevalence of obesity and metabolic disease, diverse care delivery models, and an emphasis on minimally invasive alternatives. In several Asia-Pacific markets, high-volume specialty clinics and consumer interest in less invasive options have encouraged manufacturers to develop localized training and patient support programs.

Across regions, supply chain considerations, regulatory timelines, and the maturity of reimbursement pathways shape go-to-market approaches. For example, regions with strong outpatient clinic networks may prioritize devices optimized for day-case procedures and limited anesthesia resources. Conversely, where hospital-centric care dominates, integrated service offerings that include clinician training, post-procedural monitoring, and durable follow-up will be more impactful. Effective regional strategies blend global clinical evidence with locally relevant real-world data and stakeholder engagement to build durable acceptance among clinicians, payers, and patients.

Competitive company strategies emphasizing device innovation, bundled clinical services, and partnership models to drive adoption and operational scale

Key companies operating in the intragastric balloon arena have converged around several strategic imperatives: clinical differentiation, service-oriented commercialization, and operational scalability. Leading device developers invest in iterative device design improvements to reduce adverse events and to simplify placement and removal workflows. Firms are also expanding portfolio breadth to include both gas-filled and liquid-filled endoscopic options, enabling them to address diverse clinician preferences and patient physiologies. Beyond devices, companies increasingly bundle training, patient engagement platforms, and follow-up services to improve outcomes and to reduce the burden on provider staff.

Strategic partnerships have become a common pathway to accelerate adoption; alliances with bariatric centers, specialty clinics, and distribution partners allow companies to demonstrate real-world effectiveness while building referral networks. Some players have pursued regional manufacturing relationships to enhance supply resilience and to optimize landed cost structures. In parallel, competitive differentiation is being sought through evidence generation-prospective registries, multi-center studies, and health economic analyses-to support payer engagement and to inform clinical guidelines. Companies that successfully balance product innovation with scalable service delivery and robust clinical evidence are positioning themselves to win favor among large health systems, outpatient providers, and specialist clinics seeking predictable outcomes and streamlined operations.

Actionable commercial, clinical, and supply chain measures for leaders to build resilient adoption pathways and align stakeholders around value delivery

Industry leaders should prioritize an integrated approach that aligns clinical evidence, service delivery, and supply chain resilience to accelerate sustainable adoption of intragastric balloon solutions. First, invest in robust real-world evidence generation and patient-reported outcomes to substantiate clinical claims across both preoperative optimization and standalone weight loss applications, thereby easing payer discussions and clinician acceptance. Second, create comprehensive training and credentialing pathways tailored to the needs of bariatric centers, outpatient clinics, and specialty clinics to reduce procedural variability and enhance safety profiles. Third, diversify sourcing and logistics strategies to mitigate exposure to tariff volatility and to shorten lead times, including localized manufacturing partnerships where commercially feasible.

Additionally, adapt commercial models to support different purchasing behaviors across hospital pharmacies and retail pharmacy channels by providing transparent total-cost-of-care communications and flexible contracting terms. Leverage digital patient engagement tools and multidisciplinary support programs to improve adherence to lifestyle interventions and to extend follow-up capabilities without overburdening clinical staff. Finally, pursue strategic collaborations with payer stakeholders to establish value-based arrangements or coverage pathways that reflect the long-term clinical and economic benefits of integrated obesity care. Collectively, these actions will strengthen the value proposition for intragastric balloons and support durable, scalable adoption across care settings.

Comprehensive mixed-methods research approach combining clinical interviews, regulatory review, and supply chain analysis to validate actionable insights

The research underpinning this report employed a mixed-methods approach to ensure that insights reflect both clinical realities and commercial dynamics. Primary inputs included structured interviews with clinicians across bariatric centers, outpatient specialty clinics, and hospital-based programs, as well as discussions with procurement leads and distribution partners active in hospital pharmacy and retail pharmacy channels. Secondary inputs comprised regulatory publications, clinical trial registries, and peer-reviewed literature focusing on device safety, efficacy, and patient-reported outcomes. Triangulation of these data sources enabled identification of consistent themes around device performance, procedural workflows, and barriers to adoption.

Analytical methods included comparative assessment of device design attributes-such as fill media and delivery systems-against procedural outcomes and care setting requirements. Supply chain and commercial impact analysis incorporated scenario testing to evaluate responses to tariff changes and sourcing disruptions, with attention to procurement behavior across different end-user environments. Throughout, findings were validated with clinician advisory panels and supply chain experts to ensure practical relevance and to surface actionable implications for manufacturers, providers, and payer stakeholders. The methodology emphasizes transparency in data sources and analytical assumptions while prioritizing clinical applicability and strategic utility for decision-makers.

Concluding synthesis highlighting the clinical, commercial, and operational levers that will determine successful adoption across diverse care settings

In summary, intragastric balloons have matured into a strategically important tool within contemporary obesity care, positioned between conservative medical management and surgical options. Device innovations, improved clinical protocols, and integrated care models have collectively enhanced safety and broadened applicability, creating meaningful opportunities for adoption across bariatric centers, outpatient clinics, and hospital systems. Nevertheless, commercial success depends on more than device performance; it requires demonstrable outcomes, clear reimbursement pathways, resilient supply chains, and scalable service models that support clinician training and patient engagement.

Tariff fluctuations and regional regulatory variability introduce complexity, but they also present opportunities for manufacturers to differentiate through transparent pricing, localized partnerships, and evidence-based commercial strategies. By aligning product development with end-user needs-taking into account the distinctions between endoscopic gas versus liquid options, varied clinic infrastructures, and distribution channel requirements-stakeholders can create compelling value propositions that resonate with providers and payers. The path forward favors those who couple clinical rigor with pragmatic commercialization to deliver reproducible outcomes and efficient care delivery.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of adjustable intragastric balloons enabling personalized weight management protocols
  • 5.2. Integration of intragastric balloon therapy with digital health platforms for remote patient monitoring and engagement
  • 5.3. Development of biodegradable intragastric balloon systems designed to eliminate endoscopic removal procedures
  • 5.4. Clinical studies assessing combined use of intragastric balloons with GLP-1 agonists for synergistic weight loss outcomes
  • 5.5. Emergence of shape-memory polymer balloons offering dynamic volume adjustment in response to gastric motility changes
  • 5.6. Regulatory clearances for novel air-filled intragastric balloons minimizing patient discomfort and procedural complexity
  • 5.7. Expansion of intragastric balloon applications to address nonalcoholic fatty liver disease and metabolic syndrome management
  • 5.8. Strategic collaborations between endoscopy device makers and telehealth providers to broaden balloon therapy accessibility

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intragastric Balloon Market, by Type

  • 8.1. Endoscopic
    • 8.1.1. Gas
    • 8.1.2. Liquid
  • 8.2. Non Endoscopic

9. Intragastric Balloon Market, by End User

  • 9.1. Bariatric Centers
  • 9.2. Clinics
    • 9.2.1. Outpatient Clinics
    • 9.2.2. Specialty Clinics
  • 9.3. Hospitals

10. Intragastric Balloon Market, by Distribution Channel

  • 10.1. Hospital Pharmacies
  • 10.2. Retail Pharmacies

11. Intragastric Balloon Market, by Application

  • 11.1. Preoperative Optimization
  • 11.2. Weight Loss

12. Intragastric Balloon Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Intragastric Balloon Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Intragastric Balloon Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Apollo Endosurgery, Inc.
    • 15.3.2. Allurion Technologies, Inc.
    • 15.3.3. Obalon Therapeutics, Inc.
    • 15.3.4. ReShape Lifesciences, Inc.
    • 15.3.5. Spatz Medical, Inc.
    • 15.3.6. MedSil, UAB
    • 15.3.7. Silimed, S.A.
    • 15.3.8. ENDALIS GmbH
    • 15.3.9. GI Dynamics, Inc.
    • 15.3.10. BARIATRX Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS INTRAGASTRIC BALLOON MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. INTRAGASTRIC BALLOON MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. INTRAGASTRIC BALLOON MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. INTRAGASTRIC BALLOON MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY GAS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY GAS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY GAS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY GAS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY GAS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY GAS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY LIQUID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY LIQUID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY LIQUID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY LIQUID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY NON ENDOSCOPIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY NON ENDOSCOPIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY NON ENDOSCOPIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY NON ENDOSCOPIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY NON ENDOSCOPIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY NON ENDOSCOPIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY BARIATRIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY BARIATRIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY BARIATRIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY BARIATRIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY BARIATRIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY BARIATRIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY OUTPATIENT CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY OUTPATIENT CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY OUTPATIENT CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY OUTPATIENT CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY PREOPERATIVE OPTIMIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY PREOPERATIVE OPTIMIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY PREOPERATIVE OPTIMIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY PREOPERATIVE OPTIMIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY PREOPERATIVE OPTIMIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY PREOPERATIVE OPTIMIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY WEIGHT LOSS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY WEIGHT LOSS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY WEIGHT LOSS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY WEIGHT LOSS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY WEIGHT LOSS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY WEIGHT LOSS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. AMERICAS INTRAGASTRIC BALLOON MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 98. AMERICAS INTRAGASTRIC BALLOON MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 99. AMERICAS INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 100. AMERICAS INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 101. AMERICAS INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 102. AMERICAS INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 103. AMERICAS INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 104. AMERICAS INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 105. AMERICAS INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 106. AMERICAS INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 107. AMERICAS INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 108. AMERICAS INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 109. AMERICAS INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 110. AMERICAS INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. NORTH AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 114. NORTH AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 116. NORTH AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 118. NORTH AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 120. NORTH AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 122. NORTH AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 124. NORTH AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. LATIN AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 128. LATIN AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 130. LATIN AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 132. LATIN AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 134. LATIN AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 136. LATIN AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 138. LATIN AMERICA INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 153. EUROPE INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. EUROPE INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. EUROPE INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 156. EUROPE INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 157. EUROPE INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 158. EUROPE INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 159. EUROPE INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 160. EUROPE INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 161. EUROPE INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 162. EUROPE INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 163. EUROPE INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 164. EUROPE INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 165. EUROPE INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 166. EUROPE INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. MIDDLE EAST INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. MIDDLE EAST INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 172. MIDDLE EAST INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 174. MIDDLE EAST INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 176. MIDDLE EAST INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 178. MIDDLE EAST INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 180. MIDDLE EAST INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 181. AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 185. AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 186. AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 187. AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 189. AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 190. AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 191. AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 192. AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 193. AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 194. AFRICA INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. ASEAN INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. ASEAN INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. ASEAN INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. ASEAN INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. ASEAN INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 216. ASEAN INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 217. ASEAN INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. ASEAN INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 219. ASEAN INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 220. ASEAN INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 221. ASEAN INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 222. ASEAN INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 223. ASEAN INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 224. ASEAN INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 225. GCC INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GCC INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GCC INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. GCC INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. GCC INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 230. GCC INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 231. GCC INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. GCC INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. GCC INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 234. GCC INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 235. GCC INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 236. GCC INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 237. GCC INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. GCC INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPEAN UNION INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPEAN UNION INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPEAN UNION INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPEAN UNION INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPEAN UNION INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPEAN UNION INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPEAN UNION INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPEAN UNION INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 253. BRICS INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. BRICS INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. BRICS INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. BRICS INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. BRICS INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 258. BRICS INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 259. BRICS INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 260. BRICS INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 261. BRICS INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 262. BRICS INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 263. BRICS INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 264. BRICS INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 265. BRICS INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. BRICS INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. G7 INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 268. G7 INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 269. G7 INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. G7 INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. G7 INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 272. G7 INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 273. G7 INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. G7 INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 275. G7 INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 276. G7 INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 277. G7 INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 278. G7 INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 279. G7 INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 280. G7 INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 281. NATO INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. NATO INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. NATO INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. NATO INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. NATO INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 286. NATO INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 287. NATO INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 288. NATO INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 289. NATO INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 290. NATO INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 291. NATO INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 292. NATO INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 293. NATO INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 294. NATO INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL INTRAGASTRIC BALLOON MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 297. UNITED STATES INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. UNITED STATES INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 299. UNITED STATES INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 300. UNITED STATES INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 301. UNITED STATES INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 302. UNITED STATES INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 303. UNITED STATES INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 304. UNITED STATES INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 305. UNITED STATES INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 306. UNITED STATES INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 307. UNITED STATES INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 308. UNITED STATES INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 309. CANADA INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 310. CANADA INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 311. CANADA INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 312. CANADA INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 313. CANADA INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 314. CANADA INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 315. CANADA INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 316. CANADA INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 317. CANADA INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 318. CANADA INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 319. CANADA INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 320. CANADA INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 321. MEXICO INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 322. MEXICO INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 323. MEXICO INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 324. MEXICO INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 325. MEXICO INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 326. MEXICO INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 327. MEXICO INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 328. MEXICO INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 329. MEXICO INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 330. MEXICO INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 331. MEXICO INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 332. MEXICO INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 333. BRAZIL INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 334. BRAZIL INTRAGASTRIC BALLOON MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 335. BRAZIL INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2018-2024 (USD MILLION)
  • TABLE 336. BRAZIL INTRAGASTRIC BALLOON MARKET SIZE, BY ENDOSCOPIC, 2025-2032 (USD MILLION)
  • TABLE 337. BRAZIL INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 338. BRAZIL INTRAGASTRIC BALLOON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 339. BRAZIL INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 340. BRAZIL INTRAGASTRIC BALLOON MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 341. BRAZIL INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 342. BRAZIL INTRAGASTRIC BALLOON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 343. BRAZIL INTRAGASTRIC BALLOON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)

TABLE 344